Milwaukee has exceeded expectations at 8-6 behind the MVP play of Giannis Antetokounmpo, but the Bucks have struggled by ...

Central government's 8th Pay Commission terms of reference have drawn criticism from retired employee bodies like AIDEF. They ...

NexMetals Mining Corp. (TSXV: NEXM) (NASDAQ: NEXM) (the "Company" or "NEXM") is pleased to announce the successful closing of ...

Highlights: Commissioning and operations team fully mobilised to site at Kiniéro Gold Project as Robex prepares for first ...

On November 6, 2025, the Centers for Medicare & Medicaid Services (CMS) announced a new drug payment model designed to make Most Favored ...

The No UPCODE Act—with some refinements—is a good start insofar it establishes some key pieces of reform, but a broader ...

Metro, RER, Transilien, and tramway in Paris and Île-de-France: from Monday, November 17 to Sunday, November 23, 2025, public ...

Under Armour Inc A stock has reached a new 52-week low, trading at 4.34 USD. This milestone reflects a significant downturn for the sportswear company, which has seen a notable decrease in its stock ...

The Company announced it has executed a lease agreement on a 6.9 MW DC ground-mount solar power project known as the NY-Crawford Rd project in the Capital District, New York. The Company will continue ...

Arrowhead Pharmaceuticals faces key FDA decisions, legal challenges, and trial results. Read the latest analysis on the stock ...

Investing.com -- Arcutis Biotherapeutics Inc (NASDAQ:ARQT) stock rose 4.5% on Monday after the FDA accepted the company’s application to expand the use of its psoriasis treatment to younger children.